Vaccines

ARTES offers a range of vac­cine pro­duc­ing cell lines and process­es for out-licens­ing and tech­nol­o­gy trans­fer. All list­ed cell lines are based on our safe and high yield yeast expres­sion sys­tem Hansenu­la poly­mor­pha.



Avian Flupre-clin­i­cal PoC; based on METAVAX® VLP plat­form high­ly immuno­genic, adju­vant-free; cell line and process available
Hepati­tis Blicensed world­wide; new tech­nol­ogy with improved yield; RCB, USP, DSP IPC/QC pro­to­cols available
HPV
(L1‑6; ‑11; ‑16; ‑18)
RCB, USP, DSP IPC/QC pro­to­cols for the dif­fer­ent serotypes available


To obtain a quote, please con­tact us at info(at)artes-biotechnology.com indi­cat­ing name of the vac­cine of inter­est to you. We will revert to you with a ded­i­cat­ed offer spec­i­fy­ing deliv­ery times and costs.

Enzymes & Proteins

ARTES offers a range of enzyme pro­duc­ing cell lines and process­es for out-licens­ing and tech­nol­o­gy trans­fer. All list­ed cell lines are based on our safe and high yield yeast expres­sion sys­tems Hansenu­la poly­mor­pha or E.coli.



NameDonor organ­ismEC num­ber
Phy­taseAspergillus ficu­um3.1.3.8
CalB LipaseCan­di­da antarctica3.1.1.3
Endoglu­canase IITri­cho­der­ma reesei3.2.1.4
Algi­nate EpimeraseAzo­to­bac­ter vinelandii5.1.3
D‑Galac­tose-1-Dehy­dro­ge­naseXan­thomonas campestris1.1.1.48
3‑al­pha-Hydrox­ys­teroid-Dehy­dro­ge­nasePseudomonas spec.1.1.1.50
Cel­lobio­hy­dro­lase ITri­cho­der­ma viride3.2.1.91
Cel­lobio­hy­dro­lase IITri­cho­der­ma reesei3.2.1.91
Endoglu­canase ITri­cho­der­ma reesei3.2.1.4
alpha-Man­nosi­daseAspergillus saitoi3.2.1.113
alpha-Amy­laseSchwan­niomyces occidentalis3.2.1.1
endo-ß‑1,4‑XylanasePeni­cil­li­um simplicissimum3.2.1.8
Pro­teinAsyn­thet­ic based on Staphy­lo­coc­cus aureusnot applic­a­ble
EndoHStrep­to­myces plicatus3.2.1.96


To obtain a quote, please con­tact us at info(at)artes-biotechnology.com indi­cat­ing name of the cell line of inter­est to you. We will revert to you with a ded­i­cat­ed offer spec­i­fy­ing deliv­ery times and costs.

Biosimilars

ARTES offers a range of biosim­i­lar pro­duc­ing cell lines and process­es for out-licens­ing and tech­nol­o­gy trans­fer. The list­ed cell lines are based on yeast, E. coli or mam­malian expres­sion system.



Inter­feron alpha2ayeast; mar­keted in Mena region; new tech­nol­ogy with improved yield; RCB, USP, DSP IPC/QC pro­to­cols avail­able; PEGy­lated process available
Inter­feron alpha2byeast; licensed to India; RCB, USP, DSP IPC/QC pro­to­cols avail­able; PEGy­lated process available
Hirudinyeast; mar­keted in Mena region; new tech­nol­ogy with improved yield avail­able, MCB/WCB, USP, DSP, IPC/QC pro­to­cols available
Bivalirudinyeast; licensed to Egypt; RCB, USP, DSP IPC/QC pro­to­cols available
Full length fac­tor VIIImam­malian; MCB/WCB, USP, DSP IPC/QC pro­to­cols available
Insulinyeast; cell line and process as mar­keted in India; RCB, USP, DSP IPC/QC pro­to­cols available
Detemiryeast; RCB, USP pro­to­cols avail­able; IPC/QC & DSP devel­op­ment time: approx. 6 months
Liraglu­tideyeast; RCB, USP pro­to­cols avail­able; IPC/QC & DSP devel­op­ment time: approx. 6 months
Lisproyeast; proof-of-con­cept for expres­sion achieved; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
Glarginyeast; proof-of-con­cept for expres­sion achieved; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
Tedug­lu­tideyeast; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
Aspartyeast; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
G‑CSFE. coli; RCB, USP pro­to­cols avail­able; IPC/QC & DSP devel­op­ment time: approx. 6 months
hGrowth Hor­moneyeast; RCB, USP pro­to­cols avail­able, IPC/QC & DSP devel­op­ment time: approx. 6 months
PTHyeast; MCB/WCB, USP; DSP IPC/QC pro­to­cols available
Fol­li­cle stim­u­lat­ing Hormonemam­malian; MCB/WCB, USP, DSP IPC/QC pro­to­cols available
Staphy­lok­i­naseyeast; RCB, USP, DSP IPC/QC pro­to­cols available
HSAyeast; RCB, USP pro­to­cols avail­able; IPC/QC & DSP devel­op­ment time: approx. 6 months 


To obtain a quote, please con­tact us at info(at)artes-biotechnology.com indi­cat­ing name of the biosim­i­lar process of inter­est to you. We will revert to you with a ded­i­cated offer spec­i­fy­ing deliv­ery times and costs.